Lumos Signs Major Development and IP Agreements with Hologic
Filed with ASX · · 3 pages · English
Lumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Commercial Operations Update Webinar Presentation
- LDX Raises A$2.65 Million in Successful Placement
- FDA Grants EUA for ViraDx
- FY23 Full Year Results Investor Presentation
- FY23 Full Year Results Announcement
Later from Lumos Diagnostics
- Lumos Appoints Henry Schein as US Distributor for FebriDx
- Half Year Results Investor Presentation
- Lumos Achieves Key Phase 1 Milestone in Hologic Agreement
- Lumos Receives Second US$5 million Hologic IP Payment
- Lumos Expands Distribution for FebriDx in AUS and NZ
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics